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Abstract
Background: One of the most important tuberculosis control action is the early detection, especially of multidrug-resistant tuberculosis. Cultural methods 
remain the golden standard for pulmonary tuberculosis diagnosis. The microscopic identification of acid-fast-bacilli in sputum is still a worldwide used 
method for TB detection. The low sensibility of conventional microscopic methods endangers the actual epidemiological situation. Starting with 2012, 
the genetic-molecular technology – Xpert MTB/RIF Assay - was implemented in the Republic of Moldova. The assessment of initial experience of Xpert 
MTB/RIF Assay is compulsory for improving the early case detection. The aim of the study is the assessment of extrinsic factors predictable in positive 
Xpert MTB/RIF patients.
Material and methods: A retrospective, selective, descriptive and case-control study was performed. There were enrolled 361 new pulmonary tuberculosis 
patients, diagnosed and hospitalized in the Muncipal Clinical Hospital of Phthysiopneumology of Chisinau in the period of 01.01.2014 - 01.01.2015. The 
patients were disributed into 2 groups: I - 174 patients with positive Xpert MTB/RIF Assay result; II - 187 patients with negative Xpert MTB/RIF Assay 
result. Investigations were performed according to the National Clinical Protocol – 123 Tuberculosis in adults.
results: The male gender was predominating above the female gender in both groups: 67,8% vs 32,2% in the 1st group and 55,6% vs 44,4% in the 2nd group. 
According to the economical status, disadvantaged patients were predominating in the 1st group (71,3%), as compared with the 2nd group (50.8%), with 
the degree of concludence, p<0,001. The hystory of household TB contact was predominating in the 1st group – 17,2% vs 9,1% in the 2nd group, (p<0.05).
conclusions: The implementation of Xpert MTB/RIF Assay improves the early TB detection and the prompt initiation of an adequate treatment regimen, 
according to the susceptibility testing results.
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Introduction
Tuberculosis (TB) is one of the most important challenges 
for the health care system of any state. World Health Organi-
zation (WHO) declared tuberculosis a global emergency in 
1993 [6]. In 2014, 9 million new cases were registered globally, 
the Republic of Moldova ranking among 30 countries with the 
biggest burden of multidrug-resistant tuberculosis (MDR-TB). 
One of the most relevant tuberculosis control action represents 
the early case detection, especially of MDR-TB cases [21]. So, 
precocious treatment of early detected new case is considered 
the most efficient tool for interrupting the epidemiological 
chain of infectious transmission [9]. The cultural methods 
still remain the golden standard for pulmonary tuberculosis 
diagnosis. Conventional microscopy for identification of acid-
fast-bacilli is the first step in the TB detection algorithm and 
the largely extended investigation method for the TB diagnosis 
[18]. The low sensibility of conventional microscopy methods 
endangers the actual epidemiological situation. There is not 
enough sensibility in some individual cases, and the long du-
ration in obtaining of culture results make difficult to achieve 
Millennium Goals [13, 17]. In addition, WHO established 
conditional recommendations to use Xpert MTB/RIF assay 
in adults, children and persons with HIV presumed to have 
TB (not especially MDR-TB), or for testing the non-respira-
tory specimens targeting the diagnosis of extrapulmonary 
TB [14, 20].
Xpert MTB/RIF assay represents an in-vitro diagnostic 
medical device, owned by Cepheid Company. Xpert MTB/RIF 
assay used with Cepheid Xpert MTB/RIF system is a semi-
nested, quantitative, real-time polymerase chain reaction test 
used for the DNA detection of all Mycobacterium tuberculosis 
complex species and rifampicine resistance mutations of the 
rpoB gene [7].  Xpert MTB/RIF system integrates Xpert de-
vice, a computer and a barcode reader. The system automates 
sample processing, nucleic amplification and detection of the 
target sequences of rpoB gene. Primers used by the system 
amplify the portion of the rpoB gene, containing 81 base 
bars. So, the technique is able to differentiate the wild-type 
sequence and mutation in the core region of the rpoB gene. 
The system requires the use of a single-use disposable Xpert 
cartridge that contains all the reagents necessary for deve-
loping of polymerase chain reaction process. The cartridge 
also contains the sample processing control that ensures the 
adequate processing, and the Probe Check Control (PCC) 
that verifies reagent rehydration, tube filling in the cartridge, 
probe integrity and dye stability. 
Any biological specimen (sputum, bronchoalveolar wash-
out, cerebrospinal fluid, etc.) can be processed considering 
that it requires the minimum of 2 ml of sample volume. For 
the highest sensibility, the collection procedure, the storing 
and transportation should be performed at maximum 35ºC, 
less than in 3 days, and from 2 to 8ºC, for 4 – 10 days after the 
specimen harvesting [5, 8 ]. The Xpert System generates results 
measured according to fluorescent signals. Several standard 
results must be known for the appropriate interpretation of 
Xpert MTB/RIF system: 1. MTB detected & RIF resistant 
means that MTB target is present and mutation of rpoB gene 
is detected; 2. MTB detected & RIF susceptible means that 
MTB target is present and no mutation of rpoB gene has been 
detected; 3. MTB not detected – MTB target is not detected 
within the sample. Despite of clearly defined interpretations, 
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the test results must be always correlated with the laboratory 
and clinical data of the investigated patient [11]. 
The approved data established that three sputum samples 
per patient examined through Xpert MTB/RIF assay show 
the sensitivity among culture positive specimens on average 
of 97.3%, and among smear positive patients – on average of 
99.5%. The specificity compared with non-tuberculosis pati-
ents was 97.9%. In the same three specimens the sensitivity for 
RIF resistance (rpoB gene mutation) detection among pheno-
typic (culture) RIF resistant patients was identified in amount 
of 96.1%, and specificity in phenotyping RIF sensitive patients 
was 98%. Error rates vary from 3% to 4%. The sensitivity is 
slightly decreased in a single sputum sample. Assessing the 
threshold of analytical sensitivity, it was argued that the bio-
logical sample must contain at least 131 colony forming units 
(CFU) per ml of sample with the confidence interval ranging 
from 106.2 CFU to 176.4 CFU. Experimentally, 9 strains of 
non-tuberculosis mycobacteria were mixed in sputum samples 
at a concentration of 106 CFU/ml, in all cases being obtained 
negative results at Xpert MTB/RIF Assay [2]. However, the 
negative result does not exclude active tuberculosis that leads 
to the necessary application of other important diagnostics 
approaches in the suspected TB patients [15]. This test couldn’t 
be used for the treatment outcomes evaluation (success or 
failure), because the MTB DNA persists for a long time after 
the antimicrobial therapy [7]. 
In actual epidemiological conditions the Republic of Mol-
dova encounters a sharp increase of MDR-TB incidence [9]. In 
2011, the rates of drug-resistance were 26% among new cases 
and 64% among previously treated cases [12]. Starting from 
April 2012, the Xpert MTB/RIF technology was implemented 
in 15 districts and municipality laboratories, as well as in pe-
nal institutions. In total there were procured 25 Xpert MTB/
RIF systems. A large number of laboratory staff was trained 
to use the new system. The initial experience of Xpert MTB/
RIF Assay is important to be assessed for the confirmation 
of its role in shortening the time for TB diagnosis (including 
resistant forms) [11], especially in a high burden region as 
Chisinau municipality, the Republic of Moldova. 
The aim of the study is the comparative research of the 
predictors in patients with Xpert MTB/RIF positive and Xpert 
MTB/RIF negative results.
Objectives: 1) Comparative assessment of the risk factors 
of pulmonary tuberculosis, according to the results of Xpert 
MTB/RIF assay. 2) Assessment of the predictive factors in 
the study groups.
Material and methods
It was performed a retrospective, selective, descriptive and 
case-control study, targeting the features of pulmonary tuber-
culosis in patients, diagnosed and hospitalized in the Muni-
cipal Clinical Hospital of Phthysiopneumology of Chisinau 
in the period of 01.01.2014-01.01.2015. Including criteria of 
the 1st Group: age > 18 years old; patient with pulmonary tu-
berculosis established as a new case; positive Xpert MTB/RIF 
Assay; including criteria of the 2nd Group: age > 18 years old; 
patient with pulmonary tuberculosis established as a new case; 
negative Xpert MTB/RIF Assay. The total number of 361 cases 
was distributed into 2 groups: the 1st group (1st Group) inclu-
ded 174 patients and the second group (2nd Group) included 
187 patients. The collection of primary material involved the 
extraction of data from medical record forms. The individual 
schedule included information about: anamnesis, clinical 
examination, results of radiological investigations (chest 
radiography, plane tomography, and computer tomography), 
results of microbiological investigations (smear microscopy by 
Ziehl-Neelson coloration and culture on classic solid medium 
Lowenstein-Jensen or liquid medium). Investigations were 
performed according to the National Clinical Protocol – 123 
Tuberculosis in adults [12]. Statistical analysis methods used 
in the study were: comparative, synthesis, discriminate ana-
lysis. The mathematical and statistical assessment was carried 
out by checking the quantitative and qualitative features. 
The accumulated material was tabled in simple and complex 
groups. Statistical study was performed using Microsoft Excel 
XP soft. The predictability value of each involved factor was 
calculated using the two by two tables. Relative risk and con-
fidence interval were calculated according to the established 
formula [14]. The interval of 1.2 to 1.6 was assessed as a low 
predictive factor, 1.6 to 2.4 – as a mild predictive factor, and 
more than 2.5 – as a high predictive factor [14].
Results and discussion
Among 174 patients with positive Xpert MTB/RIF Assay 
from the 1st Group, 103 (59.2±3.73%) microscopic positive 
Ziehl-Neelson staining cases were determined by conventional 
sputum smear microscopy, also were identified 142 (81.6 ± 
2.94) culture positive cases at solid and liquid media. Rifam-
picine resistance was established in 63 (36.2±3.64%) cases of 
the 1st Group.
In the 2d Group were included 187 Xpert MTB/RIF ne-
gative patients, 9 (4.8±1.56%) of them were positive acid-fast 
smears and 28 (14.9 ± 2.60%) were culture positive at solid 
(Lowenstein-Jensen) and liquid media (BACTEC MGIT). So, 
Xpert MTB/RIF Assay can’t replace conventional microbio-
logical methods.
Considering the analysis based on multivariate logistic 
regression, the burden of microscopic acid fast bacilli positi-
ve patients is high, being appreciated by Relative Risk (RR), 
RR=3.22 (95% CI: 2.63 - 3.96).
General characteristics, social, economical,  
and health insurance-related determinants  
of patients with pulmonary tuberculosis
The sex distribution of patients established the predomi-
nance of male sex versus female sex in both groups: 118 (67.8 ± 
3.54%) males in comparison with 56 (32.2 ± 3.54%) females in 
the 1st Group, with the degree of significance p<0.001, as well 
as in the 2nd Group - 104 (55.6 ± 3.63%) men in comparison 
with 83 (44.4 ± 3.63%) women, without achieving the conclu-
dence. Male-to-female sex ratio was 2.11/1 in the 1st Group 
and 1,25/1 in the 2nd Group. By comparing the groups, it was 
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identified a significant difference between gender distribution 
among the investigated groups. The male sex showed a low 
predictability in the patients with positive Xpert MTB/RIF 
Assay, assessed by RR=1.32 (95% CI: 1.04 - 1.67). The data 
are presented in the table 1.
The distribution of patients into age groups identified 
a similar proporion of patients in both groups. The largest 
representative group was the age group of 31-40 years old: 
51 (29.3±3.45%) patients from the1st Group versus 48 (25.7 
± 3.19%) patients from the 2nd Group, followed by the 21-30 
age group: 44 (25.3 ± 3.29%) patients of the 1st Group and 47 
(25.1 ± 3.172%) cases of the 2nd Group. The distribution in 
other age groups was similar (table 1). Regrouping the above 
exposed data in two subgroups (18 - 40 years and more than 
41 years) did not identify any difference between the preva-
lence of patients of less than 40 years comparing with older 
patients in the same group, as well as when comparing both 
groups (table 2). Considering that male sex and young age 
represented the significant features for both groups, it was 
identified that male gender was the most significant factor 
versus the young age in both groups. So, the young age was 
a neutral predictor in patients with positive Xpert MTB/RIF 
test assessed by RR=1.08 (95% CI: 0.8 - 1.34).
Economic characteristics of patients  
with pulmonary tuberculosis
The distribution of patients according to the economic status 
showed that the number of patients with an economically-steady 
state (employed) was identified in less than 1/3 part of the 1st 
Group and in 1/2 part of the 2nd Group. So, the employees were 
more frequently identified in the 2nd Group versus the 1st Group: 
92 (49.2 ± 3.65%) and 50 (28.7 ± 3.43%), respectively (p<0.001). 
Table 1
distribution of patients according to sex and age groups
Sex
1st Group (n=174) 2nd Group (n=187)
P
N M± m(%) N M ± m (%)
Men 118 67.8 ± 3.54 104 55.6 ± 3.63 <0.01
Women 56 32.2 ± 3.54 83 44.4 ± 3.63 <0.01
<20 years 9 5.1 ± 1.67 10 5.3 ± 1.64 >0,05
21 - 30 years 44 25.3 ± 3.29 47 25.1 ± 3.172 >0,05
31 - 40 years 51 29.3 ± 3.45 48 25.7 ± 3.19 >0,05
41 - 50 years 35 20.1 ± 3.03 27 14.4 ± 2.57 >0,05
51 - 60 years 25 14.4 ± 2.65 25 13.4 ± 2.48 >0,05
> 60 years 10 5.7 ± 1.76 28 14.9 ± 2.60 >0,05
Table 2
distribution of patients according to the age determinants
Age 
1st Group (n=174) 2nd Group (n=187)
P
N M± m (%) N M ± m (%)
Less 40 years 104 59.8 ± 3.71 105 56.2 ± 3.62 >0.05
More 41 years 70 40.2 ± 3.71 82 43.9 ± 3.62 >0.05
Table 3
distribution of patients according economic status
Economical Status
1st Group (n=174) 2nd Group (n=187)
P
n M ± m (%) N M ± m (%)
Employed 50 28.7 ± 3.43 92 49.2 ± 3.65 <0.001
Unemployed 83 47.7 ± 3.78 61 32.6 ± 3.42 <0.01
Retired 6 3.4 ± 1.38 12 6.4 ± 1.79 >0.05
Students 10 5.7 ± 1.76 4 2.1 ± 1.05 >0.05
Disease disability 9 5.2±1.67 10 5.3 ± 1.64 >0.05
Labor migrant 15 8.6 ± 2.12 8 4.3 ± 1.48 >0.05
Special situation 1 0.6 ± 0.57 0 0 >0.05
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statistics demonstrated that the uninsured part of Moldovan 
citizens ranges from 10% to 25% of total population, depen-
ding on the demographical state (more frequent in the rural 
area), ethnic origin (ethnic minorities are more frequently 
uninsured), and other socially disadvantaged conditions. In 
2014, 971.331 uninsured persons were identified in the Repu-
blic of Moldova [24]. In spite of the free of charge tuberculosis 
care, the lack of medical insurance determines a delayed 
detection and the lack of social assistance, the deficiency of 
active screening, the difficulty in the follow-up evaluation, 
all of these leading to lower treatment outcomes. In the Re-
public of Moldova, there are several categories of population 
that benefit of free insurance coverage: children till 18 years 
old, students of higher educational institutions, pregnant 
women, disabled persons with high and medium degree of 
disablement, retired persons, unemployed registered at the 
local territorial agencies, persons who take care of severely ill 
Table 4
distribution of patients according to economical status
Economical Status
1st Group (n=174) 2nd Group (n=187)
P
n M± m (%) n M ± m (%)
Steady-state 50 28.7 ± 3.43 92 49.2 ± 3.65 <0.001
Disadvantaged 124 71.3 ± 3.43 95 50.8 ± 3.65 <0.001
Table 5
distribution of patients according to the insurance status
Insurance Status
1st Group (n=174) 2nd Group (n=187)
P
n M ± m (%) n M ± m (%)
Insured 76 43.7 ± 3.76 127 67.9 ± 3.41 <0.001
Uninsured 98 56.3 ± 3.76 60 32.1 ± 3.41 <0.001
Table 6
distribution of patients according to the civic status
Civic Status
1st Group (n=174) 2nd Group (n=187)
P
n M ± m (%) n M ± m (%)
Married 60 34.5 ± 3.60 86 45.9 ± 3.64 <0.05
State marriage 8 4.6 ± 1.58 1 0.5 ± 0.53 >0.05
Unmarried 59 33.9 ± 3.58 79 42.2 ± 3.61 >0.05
Divorced 32 18.4 ± 2.93 17 9.1 ± 2.10 <0.01
Widow 15 8.6 ± 2.12 4 2.1 ± 1.05 >0.05
Unemployed represented the most expressed group, and were 
more often identified in the 1st Group versus the 2nd Group: 
83 (47.7 ± 3.78%) and 61 (32.6 ± 3.42%), respectively (p<0.01). 
Retired patients, disease disabled and students were revealed at 
the same level in both groups. Labor migrants were an important 
part of patients from both groups (table 3). 
So, economically disabled patients that included all non-
economically productive patients, such as unemployed, retired 
and students were most prevalent in the 1st Group - 124 (71.3 
± 3.43%) patients comparing with 95 (50.8 ± 3.65%) cases in 
the 2nd Group. Economical vulnerability was identified as 
middle predictive factor in patients with positive Xpert MTB/
RIF test assessed by RR=1.66 (95% CI: 1.29 - 1.2.14) (table 4).
Health insurance related issues
Health insurance represents the major condition for ac-
cessing the health care in the Republic of Moldova. General 
Table 7
distribution of patients according to the civic state
Civic Status
1st Group (n=174) 2nd Group (n=187)
P
n M ± m (%) n M ± m (%)
In couple 68 39.1 ± 3.69 87 46.5 ± 3.64 >0.05
Single-civil 106 60.9 ± 3.69 100 53.5 ± 3.64 >0.05
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persons, mothers with 4 and more children, socially disadvan-
taged families benefiting of social assistance [25]. So, including 
all above mentioned individuals, the uninsured patients were 
more frequently identified in the 1st Group comparing to 
the 2nd Group: 98 (56.3 ± 3.76%) versus 60 (32.1 ± 3.41%) 
patients, respectively, p<0.001 (table 5). Uninsured state was 
identified as middle predictive factor in patients with positive 
Xpert MTB/RIF Assay and was assessed by RR=1.68 (95% 
CI: 1.33 - 2.14). 
When studying the civil status, it was identified a higher 
rate of married patients in the 1st Group and a similar rate 
of married and unmarried patients in the 2nd Group. By 
comparing the groups, it was identified the prevalence of 
married patients in the 2nd Group versus the 1st Group: 86 
(45.9 ± 3.64%) versus 60 (34.5 ± 3.60%), respectively, with a 
low degree of significance (p<0.05). On the other hand, the 
divorced patients predominated in the 1st Group comparing 
with the 2nd Group: 32 (18.4 ± 2.93%) versus 17 (9.1 ± 2.10%) 
cases, respectively, with high degree of significance (p<0.01) 
(table 6). 
By redistributing patients into 2 groups, according to 
the civil status, the prevalence of married, recognized as in 
couple individuals was identified in the 2nd Group [87 (46.5 
± 3.64%)], comparing with cases in the 1st Group [68 (39.1 
± 3.69%) cases] and the single-civil state patients in the 2nd 
Group [100 (53.5 ± 3.64%) cases] compared with the 1st Group 
[106 (60.9 ± 3.69%) cases] without achieving the degree of 
significance (table 7). So, single civil state was identified as 
neutral predictive factor in the patients with positive  Xpert 
MTB/RIF test being assessed by RR=1.17 (95% CI: 0.93 - 1.46).
Considering all above exposed data, a rank diagram with 
the most relevant general, economical and social characte-
ristics of the pulmonary tuberculosis patients, according to 
the Xpert MTB/RIF test result was made. According to the 
schematic representation, the most relevant social features 
of patients with pulmonary tuberculosis are: disadvantaged 
economical state of the patients, followed by the male sex, 
single civil status, young age of the patients, lack of obligatory/
compulsury health insurance policy (fig. 1).
Associated harmful habits at patients  
with pulmonary tuberculosis
 During the study were identified such harmful habits with 
the biggest impact on all stages of the pathogenesis of tuber-
culosis as: tobacco smoking, alcohol abuse, and illicit drug 
use. The most prevalent addiction in both groups was tobacco 
smoking that affected 1/3 of all investigated patients: 138 (79.3 
± 3.07%) cases in the 1st Group versus 152 (81.28 ± 2.82%) 
cases in the 2nd Group. The subgroup of alcohol abusers was 
less prevalent: 64 (36.8±3.656%) cases in the 1st Group versus 
27 (14.4 ± 2.570%) cases in the 2nd Group, p<0.05. A few drug 
users were detected in both groups (table 8).
Public health related issues  
with impact on tuberculosis epidemiology
Migration has the major impact on the spread of different 
strains of tuberculosis. In Western Europe, the most of MDR-
TB cases are diagnosed in immigrants from Eastern Europe. 
Short-term travelers and short-term residents are the most 
prevalent part of the immigrational population and the most 
vulnerable group. Most of them have an illegal state in the 
hosting country, that determins the lack of health and social 
insurance. Consequently, they couldn’t access the screening 
methods and perform an effective anti-TB treatment. So, 
Fig. 1.  Hierarchy of biologically-related and social determinants of pulmonary tuberculosis.
Table 8
distribution of patients according the harmful habits
Harmful habits
1st Group (n=174) 2nd Group (n=187)
P
n M± m (%) N M ± m (%)
Tobacco smoking 138 79.3 ± 3.07 152 81.28 ± 2.82 >0.05
Drug use 3 1.7 ± 0.99 2 1.1 ± 0.75 >0.05
Alcohol abuse 64 36.8 ± 3.66 27 14.4 ± 2.57 <0.05
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external labor migrants were 15 (8.6±2.12%) cases in the 1st 
Group and 8 (24.24 ± 7.46%) individuals - in the 2nd Group.
Detention, as a public health issue, exposes a high threat 
for multidrug resistant mycobacterial infection and active 
tuberculosis development. Patients, who started the treatment 
during the detention period and then are released from the 
detention/prison, have an increased risk to be lost from follow 
up, due to the lack of interventions to ensure the continuity of 
tuberculosis treatment. There were limited cases of ex-detai-
nees in both groups: 10 (5.75 ± 1.76%) cases in the 1st Group 
and 13 (6.95 ± 1.86%) cases - in the 2nd Group. 
Epidemiological risk factors of patients  
with pulmonary tuberculosis
For the TB control and interruption of epidemiological 
chain, it is very important to early identify the index-case. The 
most epidemiological danger represents MDR-TB household 
contact and the contact with a deceased.  So, in our study were 
identified 3 groups of patients according to index case.  The 
first group of TB clusters included the household or family 
contact, a part of this group was represented by the MDR-TB 
contact and the contact with a deceased. In the next group 
were included the patients with close contact, followed by the 
patients from penitentiary institutions.
Household contact prevailed in the 1st Group, 30 (17,2 ± 
2,86% ) patients compared to 17 (9,1 ± 2,1%) patients from 
the 2nd Group, with the degree of significance, p <0.05, 
and close contact (labor, neighborhood) was identified in 
25 (14.97 ± 2.97%) cases in the 1st Group compared to 34 
(18.18 ± 2.82% ) cases in the 2nd Group, without achieving 
the degree of significance. Less prevalent was identified the 
epidemiological impact received by the institutionalization. 
Ex-prisoners were 10 (5.7 ± 1.76%) patients in the 1st Group 
and 13 (6.9 ± 1.86%) cases in the 2nd Group, without the 
degree of significance (table 9).
MDR-TB index-cases contact was identified in 4 (2.3 ± 
1.13%) cases in the 1st Group and in 2 (1.1 ± 0.75% ) cases 
in the 2nd Group, without the degree of significance; 3) dead 
patient contact was identified in 13 (7.5 ± 1.99%) cases in 
the 1st Group and in 5 (2.7 ± 1.18%) cases in the 2nd Group, 
without  the degree of significance. 
So, household TB contact was identified as a low predictive 
factor in the patients with positive Xpert MTB/RIF test, being 
assessed by RR=1.467 (95% CI: 1.145 - 1.88).
Impact of extrinsic determinants in patients  
with the positive Xpert MTB/rIF Assay results
By assessing all above exposed data that express the 
general, social, economic, and insurance-related features of 
patients with pulmonary tuberculosis, positive/negative  Xpert 
MTB/RIF test through multivariate logistic regression statis-
tical model, it was identified the prevalence only of several 
extrinsic factors: male sex, economically disadvantaged state, 
TB contact, lack of insurance (table 10).
Actual study revealed that epidemiological danger of pati-
ents with positive Xpert MTB/RIF was reduced by shortening 
the duration of tuberculosis diagnosis. 
Conclusions
This study was first realized in Municipal Clinical Hospital 
of Phthysiopneumology of Chisinau. 
Table 9
distribution of patients according to the characteristics of epidemiological cluster
Index
1st Group (n=174) 2nd Group n=187
P
n M ± m(%) N M ± m (%)
Household/ Family contact 30 17,2 ± 2.86 17 9.1 ± 2.1 <0.05
Close contact 25 14.37 ± 2.65 34 18.18 ± 2.82 >0.05
Institutional/ Penitentiary contact 10 5.7 ± 1.76 13 6.9 ± 1.86 >0.05
Total 65 37,4 ± 3,66 64 34.2 ± 3.47 >0.05
Table 10
relative risk from multivariate logistic regression model assessing factors associated to Xpert MTB/rIF Assay (n=361)
Factors Relative Risk 95% CI P
Male sex 1.32 1.04-1.67 <0.01
Young age (Less than 40) 1.08 0.8-1.34 >0.05
Economically disadvantaged state 1.66 1.29-2.14 <0.001
Uninsured state 1.68 1.33-2.14 <0.001
Single-civil state 1.17 0.93-1.46 >0.05
Epidemiological danger by being microscopic positive case-index 3.22 2.63-3.96 <0.001
 Household TB Contact 1.467 1,145-1.88 <0.05
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Despite of multiple extrinsic factors assessed in the study, 
the multivariate logistic regression model determined that 
male individuals, young age, single state and household TB 
contact had low risk to be positive at Xpert MTB/RIF Assay, 
assessed by Relative Risk; economically disadvantaged pati-
ents and patients with lack of insurance had middle risk and 
microscopic positive patients had high risk to be positive at 
Xpert MTB/RIF assay. 
The use of Xpert MTB/RIF could improve TB control pro-
gram and epidemiological situation by earliest TB detection 
for achieving the epidemiological indicators, recommended 
by WHO.
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